SEELQ / Seelos Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Seelos 治療公司
US ˙ OTCPK

已發行股份 1,362,879 shares
內部人士股份22,849,770 shares
所有內部人士33
內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果,該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例,以及內部人士擁有的總股份的指標。該分數的範圍從0到100,數值越高表示相對於同行業而言具有更高程度的內部人士持股水平,50為平均值。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義,公司高管是公司內部人士,但與其他內部人士(10%的股東和董事會成員)不同,公司高管每天在公司工作,而且他們使用自己的資金進行交易。(10%的股東和董事會成員通常是基金經理,管理著其他人的資金。)因此,公司高管進行的內幕交易更為重要性,應該被適當地重視和關注。

如同「內部人士情緒分數」,「高管情緒分數」也是一個複雜的多因素量化模型的計算結果,該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說,一般認為內部人士的買入是一個積極的指標,因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少(甚至有內部人士賣出)的公司。

內部人士買入淨數(排名)

0 ( )
4346 out of 10948

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示(範圍從0到100%)。

內部人士買入佔流通股比例(排名)

0.000% ( )
4319 out of 10786

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數,除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Seelos Therapeutics, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單,從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外,我們還提供了最新披露的持股信息。此外,我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊,請查看YouTube網絡研討會

See our leaderboard of most profitable insider traders.

內部人士 平均收益(%) 持股
數量
分拆
調整
Armistice Capital, Llc 10% Owner - [10%] 18,400,000 18,400,000
Armistice Capital Master Fund Ltd. 10% Owner - [10%] 18,400,000 18,400,000
Randy Berholtz 55,000
Catherine Bovenizer VP Finance & CAO - [O] 34,594 34,594
Steven Boyd 10% Owner - [10%] 18,400,000 18,400,000
Cox Edward M. VP of Corporate Development - [O] 158,541 158,541
Roberto Crea Director - [D] 29,655 2,542
Margaret Dalesandro Director - [D] 35,000 1,944
Alexander J Denner 10% Owner - [10%] 1,447,906 1,447,906
Bassam Damaj President and CEO, Director - [D] [O] 1,611,747 1,611,747
Brian Dorsey - 115,891 115,891
內部人士 平均收益(%) 持股
數量
分拆
調整
Judith Dunn 16,000
Henry Jemil Esber Director - [D] 609,217 609,217
Deirdre Gillespie Director - [D] 15,433 15,433
Michael Joseph Golembiewski Chief Financial Officer - [O] 86,869 7,239
Brian Lian 35,000
Paul V Maier Director - [D] 13,854 13,854
Steven Robert Martin Senior VP & CFO - [O] 20,000 20,000
Raj Mehra See Remarks, Director - [D] [O] 185,142 15,428
Neil Morton SVP, Chief Business Officer - [O] 100,158 100,158
Daniel O'Connor Director - [D] 16,000 889
Leonard A Oppenheim Director - [D] 20,449 20,449
內部人士 平均收益(%) 持股
數量
分拆
調整
Richard W Pascoe CEO & Secretary, Director - [D] [O] 155,396 155,396
Rusty Ray Director - [D] 16,955 16,955
Sandford D Smith Director - [D] 16,160 16,160
Sarissa Capital Domestic Fund LP 10% Owner - [10%] 1,447,906 1,447,906
Sarissa Capital Management LP 10% Owner - [10%] 653,409 1,447,906
Sarissa Capital Offshore Master Fund LP 10% Owner - [10%] 653,409 1,447,906
Robin L Smith 16,000
David S Tierney Director - [D] 18,200 1,560
Barbara Troupin SVP, Chief Medical Officer - [O] 43,918 43,918
Wendall Wierenga Director - [D] 15,373 15,373
Kleanthis G Xanthopoulos Director - [D] 24,575 24,575

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分,我們分析了在 SEELQ / Seelos Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2023-12-01 Mehra Raj 75,757 1.3200 6,313 15.8400 99,999 3 15.68 -1,011 -1.01
2023-11-30 Golembiewski Michael Joseph 83,000 1.2075 6,917 14.4900 100,222
2022-06-01 O'Connor Daniel 16,000 0.6118 889 11.0124 9,789
2022-05-26 DALESANDRO MARGARET 35,000 0.5990 1,944 10.7820 20,965
2022-03-31 Mehra Raj 66,667 0.8526 3,704 15.3468 56,840
2020-02-13 Mehra Raj 133,333 0.7500 7,407 13.5000 100,000
2017-08-31 DENNER ALEXANDER J 6,104 1.6300 6,104 1.6300 9,950

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

SEELQ / Seelos Therapeutics, Inc. Insider Trades
追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分,我們分析了在 SEELQ / Seelos Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2014-01-03 Oppenheim Leonard A 15,212 2.4933 15,212 2.4933 37,928 730

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

SEELQ / Seelos Therapeutics, Inc. Insider Trades
交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易,將在標記為 10b-5 的欄位中顯示 X。

呈報
日期
交易
日期
表格 內部人士 證券代碼 證券種類 代碼 10b5-1 直接 行使
價格
單位
價格
股數
變化
價值
變化 (1K)
剩餘
期權
剩餘
股份
2024-03-01 2024-02-29 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 1.0970 417 0 86,869
2023-12-01 2023-12-01 4 Mehra Raj SEEL Common Stock P - Purchase D 1.3200 75,757 100 185,142
2023-12-01 2023-11-30 4 Golembiewski Michael Joseph SEEL Common Stock P - Purchase D 1.2075 83,000 100 86,450
2023-09-01 2023-08-31 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 0.6180 12,500 8 103,487
2023-03-02 2023-02-28 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 0.6720 12,500 8 90,987
2022-06-02 2022-06-01 4 O'Connor Daniel SEEL Common Stock P - Purchase D 0.6118 16,000 10 16,000
2022-05-27 2022-05-26 4 DALESANDRO MARGARET SEEL Common Stock P - Purchase D 0.5990 35,000 21 35,000
2022-03-31 2022-03-31 4 Mehra Raj SEEL Common Stock P - Purchase D 0.8526 66,667 57 3,281,546
2022-03-04 2022-02-28 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 0.9010 12,500 11 78,487
2022-01-11 2022-01-10 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 1.46 1,300,000 1,300,000
2022-01-11 2022-01-10 4 Golembiewski Michael Joseph SEEL Stock Option (right to buy) A - Award D 1.46 500,000 500,000
2022-01-06 2022-01-05 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 1.56 35,000 35,000
2022-01-06 2022-01-05 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 1.56 35,000 35,000
2022-01-06 2022-01-05 4 DALESANDRO MARGARET SEEL Stock Option (right to buy) A - Award D 1.56 35,000 35,000
2022-01-06 2022-01-05 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 1.56 35,000 35,000
2021-09-02 2021-09-01 4 DALESANDRO MARGARET SEEL Stock Option (right to buy) A - Award D 2.16 42,000
2021-09-02 3 Golembiewski Michael Joseph SEEL Common Stock D 65,987
2021-03-17 2021-03-15 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 4.31 1,150,000 1,150,000
2021-01-08 2021-01-06 4 Dunn Judith SEEL Stock Option (right to buy) A - Award D 1.35 16,000 16,000
2021-01-08 2021-01-06 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 1.35 16,000 16,000
2021-01-08 2021-01-06 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 1.35 16,000 16,000
2021-01-08 2021-01-06 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 1.35 16,000 16,000
2020-06-12 2020-06-11 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 1.08 2,282,262 2,282,262
2020-05-15 2020-05-15 4 Dunn Judith SEEL Stock Option (right to buy) A - Award D 0.97 16,000 16,000
2020-05-15 2020-05-15 4 Dunn Judith SEEL Stock Option (right to buy) A - Award D 0.97 24,000 24,000
2020-02-14 2020-02-13 4 Mehra Raj SEEL Common Stock P - Purchase D 0.7500 133,333 100 3,214,879
2020-01-07 2020-01-06 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 1.42 731,000 731,000
2020-01-07 2020-01-06 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 1.42 16,000 16,000
2020-01-07 2020-01-06 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 1.42 16,000 16,000
2020-01-07 2020-01-06 4 Smith Robin L SEEL Stock Option (right to buy) A - Award D 1.42 16,000 16,000
2020-01-07 2020-01-06 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 1.42 16,000 16,000
2019-03-21 2019-03-20 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 2.33 16,000 16,000
2019-03-21 2019-03-20 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 2.33 16,000 16,000
2019-03-21 2019-03-20 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 2.33 24,000 24,000
2019-03-21 2019-03-20 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 2.33 16,000 16,000
2019-03-21 2019-03-20 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 2.33 24,000 24,000
2019-03-21 2019-03-20 4 Smith Robin L SEEL Stock Option (right to buy) A - Award D 2.33 16,000 16,000
2019-03-21 2019-03-20 4 Smith Robin L SEEL Stock Option (right to buy) A - Award D 2.33 24,000 24,000
2019-01-28 2019-01-24 4 Mehra Raj SEEL Common Stock A - Award D 3,081,546 3,081,546
2019-01-24 2019-01-23 4 Morton Neil APRI Common Stock F - Taxes D 0.2265 -32,705 -7 100,158
2019-01-24 2019-01-23 4 Pascoe Richard W APRI Common Stock F - Taxes D 0.2265 -44,810 -10 155,396
2018-11-30 2018-11-30 4 Pascoe Richard W APRI Common Stock F - Taxes D 0.3060 -17,290 -5 200,206
2018-11-30 2018-11-30 4 Morton Neil APRI Common Stock F - Taxes D 0.3060 -12,968 -4 132,863
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18,400,000
2018-09-04 2018-08-30 4 Dorsey Brian APRI Common Stock F - Taxes D 0.3300 -43,225 -14 115,891
2018-09-04 2018-08-30 4 Dorsey Brian APRI Common Stock M - Exercise D 81,775 159,116
2018-03-23 2018-03-21 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock J - Other I 0.71 653,409 653,409
2018-03-23 2018-03-21 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock J - Other I 0.71 -653,409 0
2018-01-08 2018-01-04 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2.11 50,000 50,000
2018-01-08 2018-01-04 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2.11 35,000 35,000
2018-01-08 2018-01-04 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2.11 35,000 35,000
2018-01-08 2018-01-04 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 2.11 35,000 35,000
2018-01-08 2018-01-04 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 2.11 35,000 35,000
2018-01-03 2018-01-03 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 2.11 245,000 245,000
2018-01-03 2018-01-01 4 Pascoe Richard W APRI Common Stock F - Taxes D 1.8400 -7,679 -14 217,496
2018-01-03 2018-01-03 4 Morton Neil APRI Stock Option (right to buy) A - Award D 2.11 60,000 60,000
2018-01-03 2018-01-01 4 Morton Neil APRI Common Stock F - Taxes D 1.8400 -2,194 -4 145,831
2018-01-03 2018-01-03 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 2.11 60,000 60,000
2018-01-03 2018-01-01 4 Dorsey Brian APRI Common Stock F - Taxes D 1.8400 -5,485 -10 159,116
2017-09-07 2017-09-05 4 Morton Neil APRI Common Stock F - Taxes D 1.5600 -14,093 -22 148,025
2017-09-07 2017-09-05 4 Pascoe Richard W APRI Common Stock F - Taxes D 1.5600 -18,790 -29 225,175
2017-09-07 2017-09-05 4 Dorsey Brian APRI Common Stock F - Taxes D 1.5600 -14,093 -22 164,601
2017-09-01 2017-08-31 4 DENNER ALEXANDER J See footnotes APRI Warrants to purchase Common Stock P - Purchase I 8.80 2,835 672,453
2017-09-01 2017-08-31 4 DENNER ALEXANDER J See footnotes APRI Common Stock P - Purchase I 1.6300 6,104 10 1,447,906
2017-06-05 2017-06-01 4 Pascoe Richard W APRI Common Stock A - Award D 100,000 243,965
2017-06-05 2017-06-01 4 Dorsey Brian APRI Common Stock A - Award D 75,000 178,694
2017-06-05 2017-06-01 4 Morton Neil APRI Common Stock A - Award D 75,000 162,118
2017-03-24 2017-02-15 4 Pascoe Richard W APRI Common Stock F - Taxes D 2.7800 -3,712 -10 143,965
2017-03-24 2017-02-15 4 Morton Neil APRI Common Stock F - Taxes D 2.7800 -831 -2 87,118
2017-03-24 2017-02-15 4 Dorsey Brian APRI Common Stock F - Taxes D 2.7800 -1,495 -4 103,694
2017-01-06 2017-01-05 4 MAIER PAUL V APRI Common Stock A - Award D 11,250 13,854
2017-01-06 2017-01-05 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 11,250 15,373
2017-01-06 2017-01-05 4 SMITH SANDFORD D APRI Common Stock A - Award D 11,250 16,160
2017-01-06 2017-01-05 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 15,000 24,575
2017-01-06 2017-01-05 4 Pascoe Richard W APRI Common Stock A - Award D 100,000 147,677
2017-01-06 2017-01-05 4 Dorsey Brian APRI Common Stock A - Award D 75,000 105,189
2017-01-06 2017-01-05 4 Ray Rusty APRI Common Stock A - Award D 11,250 16,955
2017-01-06 2017-01-05 4 Morton Neil APRI Common Stock A - Award D 75,000 87,949
2016-10-03 2016-09-30 4 MAIER PAUL V APRI Common Stock A - Award D 0.3383 10,715 4 26,039
2016-10-03 2016-09-30 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 0.3383 8,868 3 41,228
2016-10-03 2016-09-30 4 SMITH SANDFORD D APRI Common Stock A - Award D 0.3383 9,607 3 49,093
2016-10-03 2016-09-30 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 0.3383 16,997 6 95,746
2016-10-03 2016-09-30 4 Ray Rusty APRI Common Stock A - Award D 0.3383 10,161 3 57,045
2016-07-01 2016-06-30 4 MAIER PAUL V APRI Common Stock A - Award D 0.3995 9,074 4 15,324
2016-07-01 2016-06-30 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 0.3995 7,510 3 32,360
2016-07-01 2016-06-30 4 SMITH SANDFORD D APRI Common Stock A - Award D 0.3995 8,136 3 39,486
2016-07-01 2016-06-30 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 0.3995 14,393 6 78,749
2016-07-01 2016-06-30 4 Ray Rusty APRI Common Stock A - Award D 0.3995 8,605 3 46,884
2016-05-20 2016-04-25 4/A Dorsey Brian APRI Common Stock A - Award D 0 51,891
2016-05-20 2016-04-25 4/A Morton Neil APRI Common Stock A - Award D 0 29,496
2016-05-20 2016-04-25 4/A Bovenizer Catherine APRI Common Stock A - Award D 0 34,594
2016-05-20 2016-05-20 4 Dorsey Brian APRI Common Stock A - Award D 250,000 301,891
2016-05-20 2016-05-20 4 Bovenizer Catherine APRI Common Stock A - Award D 50,000 34,594
2016-05-20 2016-05-20 4 Morton Neil APRI Common Stock A - Award D 100,000 129,496
2016-04-27 2016-04-25 4 Pascoe Richard W APRI Common Stock A - Award D 350,000 476,778
2016-04-27 2016-04-25 4 Dorsey Brian APRI Common Stock A - Award D 250,000 301,891
2016-04-27 2016-04-25 4 Bovenizer Catherine APRI Common Stock A - Award D 50,000 84,594
2016-04-27 2016-04-25 4 Morton Neil APRI Common Stock A - Award D 100,000 129,496
2016-04-07 2016-04-05 4 MAIER PAUL V APRI Common Stock A - Award D 0.5800 6,250 4 6,250
2016-04-07 2016-04-05 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 0.5800 4,850 3 24,850
2016-04-07 2016-04-05 4 SMITH SANDFORD D APRI Common Stock A - Award D 0.5800 4,850 3 31,350
2016-04-07 2016-04-05 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 0.5800 8,621 5 64,356
2016-04-07 2016-04-05 4 Ray Rusty APRI Common Stock A - Award D 0.5800 5,927 3 38,279
2016-04-05 3 Morton Neil APRI Common Stock D 58,992
2016-04-05 3 Morton Neil APRI Common Stock D 58,992
2016-04-05 2016-04-01 4 Morton Neil APRI Stock Option (right to buy) A - Award D 0.57 165,000 165,000
2016-03-17 2016-03-15 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 1.11 500,000 500,000
2016-03-17 2016-03-15 4 Pascoe Richard W APRI Common Stock A - Award D 79,778 126,778
2016-03-17 2016-03-15 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 1.11 200,000 200,000
2016-03-17 2016-03-15 4 Dorsey Brian APRI Common Stock A - Award D 41,891 51,891
2016-03-17 2016-03-15 4 Troupin Barbara APRI Stock Option (right to buy) A - Award D 1.11 200,000 200,000
2016-03-17 2016-03-15 4 Troupin Barbara APRI Common Stock A - Award D 43,918 43,918
2016-03-17 2016-03-15 4 Bovenizer Catherine APRI Stock Option (right to buy) A - Award D 1.11 85,000 85,000
2016-03-17 2016-03-15 4 Bovenizer Catherine APRI Common Stock A - Award D 34,594 34,594
2016-03-07 2016-03-03 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock P - Purchase I 0.88 3,323,864 6,724,525
2016-03-07 2016-03-03 4 DENNER ALEXANDER J APRI Common Stock P - Purchase I 0.8800 6,647,728 5,850 14,479,053
2016-01-14 2016-01-12 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock P - Purchase I 0.88 653,409 3,400,661
2016-01-14 2016-01-12 4 DENNER ALEXANDER J APRI Common Stock P - Purchase I 0.8800 1,306,819 1,150 7,831,324
2016-01-05 2016-01-04 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 0.97 25,000 25,000
2016-01-05 2016-01-04 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 0.97 25,000 25,000
2016-01-05 2016-01-04 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 0.97 50,000 50,000
2016-01-05 2016-01-04 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 0.97 25,000 25,000
2016-01-05 2016-01-04 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 0.97 25,000 25,000
2016-01-05 2016-01-04 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 0.97 25,000 25,000
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13,049,010
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13,049,010
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13,049,010
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13,049,010
2015-01-30 2015-01-29 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 1.43 150,000 150,000
2015-01-30 2015-01-29 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 1.43 300,000 300,000
2015-01-30 2015-01-29 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 1.43 50,000 50,000
2015-01-30 2015-01-29 4 Bovenizer Catherine APRI Stock Option (right to buy) A - Award D 1.43 30,000 30,000
2015-01-30 2015-01-29 4 Troupin Barbara APRI Stock Option (right to buy) A - Award D 1.43 50,000 50,000
2015-01-26 2015-01-02 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 1.20 25,000 25,000
2015-01-26 2015-01-02 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 1.20 25,000 25,000
2015-01-26 2015-01-02 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 1.20 25,000 25,000
2015-01-26 2015-01-02 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 1.20 25,000 25,000
2015-01-26 2015-01-02 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 1.20 50,000 50,000
2015-01-26 2015-01-02 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 1.20 25,000 25,000
2015-01-12 2015-01-12 4 Bovenizer Catherine APRI Stock Option (right to buy) A - Award D 1.52 150,000 150,000
2014-12-30 2014-12-29 4 Dorsey Brian APRI Common Stock P - Purchase D 1.0481 10,000 10 10,000
2014-12-22 2014-12-22 4 Pascoe Richard W APRI Common Stock P - Purchase D 1.0217 10,000 10 47,000
2014-12-15 2014-12-12 4 Troupin Barbara APRI Stock Option (right to buy) A - Award D 1.16 300,000 300,000
2014-12-02 2014-12-01 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 1.13 300,000 300,000
2014-10-24 2014-10-22 4 Ray Rusty APRI Common Stock P - Purchase D 1.4999 3,500 5 32,352
2014-10-24 2014-10-22 4 Pascoe Richard W APRI Common Stock P - Purchase D 1.5100 12,000 18 37,000
2014-10-24 2014-10-23 4 SMITH SANDFORD D APRI Common Stock P - Purchase D 1.5933 18,200 29 26,500
2014-10-24 2014-10-22 4 SMITH SANDFORD D APRI Common Stock P - Purchase D 1.5242 8,300 13 8,300
2014-10-24 2014-10-22 4 WIERENGA WENDALL APRI Common Stock P - Purchase D 1.5182 20,000 30 20,000
2014-08-12 2014-08-08 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 1.95 85,000 85,000
2014-03-11 2014-03-10 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 2.40 100,000 100,000
2014-02-24 2014-02-20 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2.38 71,000 71,000
2014-02-24 2014-02-20 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 2.38 177,500 177,500
2014-02-24 2014-02-20 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 2.38 31,950 31,950
2014-02-10 2014-02-06 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2.36 9,000 9,000
2014-02-10 2014-02-06 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2.36 34,000 34,000
2014-02-10 2014-02-06 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 2.36 9,000 9,000
2014-02-10 2014-02-06 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2.36 75,000 75,000
2014-02-10 2014-02-06 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 2.36 157,808 157,808
2014-02-10 2013-12-30 4 Pascoe Richard W APRI Common Stock G - Gift D -10,000 25,000
2014-02-10 2014-02-06 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 2.36 9,000 9,000
2014-02-10 2014-02-06 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 2.36 50,000 50,000
2014-02-10 2014-02-06 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2.36 9,000 9,000
2014-01-06 2014-01-02 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2.59 16,000 16,000
2014-01-06 2014-01-02 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2.59 16,000 16,000
2014-01-06 2014-01-03 4 Oppenheim Leonard A APRI Common Stock S - Sale D 2.4933 -15,212 -38 20,449
2014-01-06 2014-01-02 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 2.59 16,000 16,000
2014-01-06 2014-01-02 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 2.59 16,000 16,000
2014-01-06 2014-01-02 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2.59 16,000 16,000
2013-12-27 2013-12-26 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2.5500 -17,184 -44 55,735
2013-06-21 2013-06-21 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2.5200 -2,864 -7 72,919
2013-05-24 2013-05-23 4 Martin Steven Robert APRI Common Stock Warrant P - Purchase D 3.40 2.8500 20,000 57 20,000
2013-05-24 2013-05-23 4 Martin Steven Robert APRI Common Stock P - Purchase D 2.8500 20,000 57 20,000
2013-05-24 2013-05-23 4 Pascoe Richard W APRI Common Stock Warrant P - Purchase D 3.40 2.8500 35,000 100 35,000
2013-05-24 2013-05-23 4 Pascoe Richard W APRI Common Stock P - Purchase D 2.8500 35,000 100 35,000
2013-05-24 2013-05-23 4 Ray Rusty APRI Common Stock Warrant P - Purchase D 3.40 2.8500 5,000 14 5,000
2013-05-24 2013-05-23 4 Ray Rusty APRI Common Stock P - Purchase D 2.8500 5,000 14 28,852
2013-05-23 2013-05-21 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 3.3564 -2,864 -10 75,783
2013-04-22 2013-04-22 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2.6270 -2,864 -8 78,647
2013-04-01 2013-03-31 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2.68 1,371 1,371
2013-03-21 2013-03-21 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2.5000 -2,864 -7 81,511
2013-02-28 2013-02-28 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2.67 2,500 2,500
2013-02-01 2013-01-31 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2.64 2,500 2,500
2013-01-08 2013-01-07 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2.10 16,000 16,000
2013-01-08 2013-01-07 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2.10 16,000 16,000
2013-01-08 2013-01-07 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 2.10 16,000 16,000
2013-01-08 2013-01-07 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 2.10 16,000 16,000
2013-01-08 2013-01-07 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2.10 16,000 16,000
2012-12-31 2012-12-31 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 1.99 2,500 2,500
2012-12-20 2012-12-18 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2.04 75,000 75,000
2012-12-20 2012-12-18 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 2.04 27,500 27,500
2012-12-20 2012-12-18 4 Berholtz Randy APRI Stock Option (right to buy) A - Award D 2.04 55,000 55,000
2012-11-30 2012-11-30 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2.20 2,083 2,083
2012-10-01 2012-09-28 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 09/30/2011 APRI Common Stock S - Sale I 3.2506 -3,125 -10 84,375
2012-08-23 2012-08-23 4 Damaj Bassam APRI Common Stock O - Other D 249,002 1,610,987
2012-08-23 2012-08-21 4 Damaj Bassam APRI Common Stock P - Purchase D 2.7700 760 2 1,611,747
2012-08-22 2012-08-20 4 Cox Edward M. APRI Common Stock P - Purchase D 2.7270 1,500 4 158,541
2012-08-21 2012-08-20 4 Damaj Bassam APRI Common Stock P - Purchase D 2.6895 1,500 4 1,361,985
2012-08-17 2012-08-15 4 XANTHOPOULOS KLEANTHIS G APRI Common Stock S - Sale D 3.0147 -12,500 -38 87,500
2012-08-17 2012-08-17 4 Ray Rusty APRI Common Stock P - Purchase D 2.8109 4,000 11 23,852
2012-06-05 2012-06-01 4 MAIER PAUL V APRI Director Stock Option (right to buy) A - Award D 2.60 25,000 25,000
2012-03-28 2011-06-14 4 Cox Edward M. APRI Common Stock J - Other D 13,574 157,041
2012-03-28 2011-06-14 4 Damaj Bassam APRI Common Stock J - Other D 90,167 535,040
2012-03-28 2011-06-14 4 Damaj Bassam APRI Common Stock J - Other D 34,342 825,445
2012-03-07 2012-03-05 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 3.23 195,000 195,000
2012-03-07 2012-03-05 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 3.23 20,000 20,000
2012-03-07 2012-03-05 4 Damaj Bassam APRI Stock Option (right to buy) A - Award D 3.23 200,000 200,000
2012-03-07 2012-03-05 4 Berholtz Randy APRI Stock Option (right to buy) A - Award D 3.23 183,500 183,500
2012-01-04 2012-01-03 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 5.13 16,000 16,000
2012-01-04 2012-01-03 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 5.13 16,000 16,000
2012-01-04 2012-01-03 4 Oppenheim Leonard A APRI Common Stock A - Award D 5.1300 2,784 14 33,995
2012-01-04 2012-01-03 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 5.13 16,000 16,000
2012-01-04 2012-01-03 4 Gillespie Deirdre APRI Common Stock A - Award D 5.1300 2,784 14 15,433
2012-01-04 2012-01-03 4 ESBER HENRY JEMIL APRI Stock Option (right to buy) A - Award D 5.13 16,000 16,000
2012-01-04 2012-01-03 4 ESBER HENRY JEMIL APRI Common Stock A - Award D 5.1300 2,505 13 609,217
2012-01-04 2012-01-03 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 5.13 16,000 16,000
2012-01-04 2012-01-03 4 Ray Rusty APRI Common Stock A - Award D 5.1300 2,784 14 19,852
2010-01-13 2010-01-11 4 Damaj Bassam By wife NEXM Common Stock A - Award I 0.1680 204,657 34 593,090
2010-01-13 2010-01-11 4 Damaj Bassam NEXM Common Stock A - Award D 0.1680 485,443 82 1,406,804
2010-01-13 2010-01-11 4 Crea Roberto NEXM Common Stock A - Award D 0.1680 10,233 2 29,655
2010-01-13 2010-01-11 4 ESBER HENRY JEMIL By Wife NEXM Common Stock A - Award I 0.1680 120,386 20 348,876
2010-01-13 2010-01-11 4 ESBER HENRY JEMIL NEXM Common Stock A - Award D 0.1680 234,753 39 680,309
2007-02-02 3 Tierney David S NEXM Common Stock D 18,200
2004-11-03 3 Oppenheim Leonard A Through the Trust NEXM Common Stock I 104,402
2004-11-03 3 Oppenheim Leonard A Through the IRA NEXM Common Stock I 60,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista